Davis Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Davis Asset Management's BMY Position: Q2 2026 in Review
Davis Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 460 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #69.
Davis Asset Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $27.9K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Davis Asset Management held 460 shares of Bristol-Myers Squibb worth $26.5K as of Q2 2026.
- Davis Asset Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Davis Asset Management's portfolio in Q2 2026, its #69 holding.
- Davis Asset Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Davis Asset Management's Bristol-Myers Squibb position peaked at $27.9K in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Davis Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.